Robert G McNeil insider trades: Regen Biologics (RGBO) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robert reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 14, 2009 | RGBO | ↑ Buy | 10,000 | $2.96 | $30K | Direct | Apr 20, 2009 (6d) |
| Apr 3, 2009 | RGBO | ↑ Buy | 10,300 | $2.90 | $30K | Direct | Apr 3, 2009 (0d) |
| Jan 16, 2009 | RGBO | ↑ Buy | 1,142,857 | $3.50 | $4.0M | Indirect | Jan 21, 2009 (5d) |
| Sep 9, 2008 | RGBI | ↑ Buy | 50,000 | $0.10 | $5K | Indirect | Sep 9, 2008 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Robert G McNeil's insider trades
Robert G McNeil is a director at Regen Biologics (RGBO). Since Sep 9, 2008, Robert has reported 4 open-market purchases worth $4.1M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings), other transactions (3 filings), option exercises (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RGBO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.